Learn about an innovative research study
Webinar: Thursday, November 12
2:00 pm to 3:00 pm Central Time
argenx Head, Global Patient Advocacy & Policy
Lisa Carfangnini Guererro
MG Patient and Owner of Lake Street Bean, Grayslake IL
MyRealWorld MG is an international two-year study that looks at the impact of myasthenia gravis on patients’ lives. We invite you to click the Register Today button to learn more about this innovative project. The study offers a way to share your myasthenia gravis journey to help researchers understand the impact and burden of MG on patients and their families.
The study is sponsored by argenx, a biotechnology company working with patient organizations from 9 countries (US, Japan, Germany, UK, France, Italy, Spain, Canada, Belgium). argenx is inviting MG patients from around the world to participate and share information through the use of the MyRealWorld mobile app. Click here to LEARN MORE.
Please note: Conquer MG is pleased to provide information about current MG research to the MG community. Please note the study is sponsored by argenx, and all webinar content reflects the views of argenx and other panelists. Conquer MG does not endorse this or any other study.